PRFX

PainReform (PRFX)

PainReform Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PRFX

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/01	05 : 24	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2024/06/01	05 : 15	GlobeNewswire Inc.	PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification	NASDAQ:PRFX	PainReform Ltd
2024/05/16	05 : 05	GlobeNewswire Inc.	PainReform Provides Business Update for the First Quarter of 2024	NASDAQ:PRFX	PainReform Ltd
2024/05/08	21 : 30	GlobeNewswire Inc.	PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com	NASDAQ:PRFX	PainReform Ltd
2024/04/19	03 : 19	GlobeNewswire Inc.	PainReform Announces Closing of $4 Million Public Offering	NASDAQ:PRFX	PainReform Ltd
2024/04/16	21 : 00	GlobeNewswire Inc.	PainReform Announces Pricing of $4 Million Public Offering	NASDAQ:PRFX	PainReform Ltd
2024/04/09	22 : 00	GlobeNewswire Inc.	PainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions	NASDAQ:PRFX	PainReform Ltd
2024/04/02	21 : 30	GlobeNewswire Inc.	PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy	NASDAQ:PRFX	PainReform Ltd
2024/03/08	07 : 25	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2024/03/02	06 : 34	Edgar (US Regulatory)	Form F-1 - Registration statement for certain foreign private issuers	NASDAQ:PRFX	PainReform Ltd
2024/03/01	22 : 09	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2024/03/01	22 : 00	GlobeNewswire Inc.	PainReform Provides Year-End Business Update	NASDAQ:PRFX	PainReform Ltd
2024/03/01	06 : 37	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:PRFX	PainReform Ltd
2024/01/22	22 : 30	GlobeNewswire Inc.	PainReform to Present at the Microcap Conference in Atlantic City	NASDAQ:PRFX	PainReform Ltd
2024/01/22	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PRFX	PainReform Ltd
2024/01/20	06 : 30	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PRFX	PainReform Ltd
2024/01/13	06 : 15	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:PRFX	PainReform Ltd
2024/01/03	22 : 36	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2024/01/03	22 : 30	GlobeNewswire Inc.	PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief	NASDAQ:PRFX	PainReform Ltd
2023/12/28	06 : 04	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PRFX	PainReform Ltd
2023/12/28	06 : 01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2023/12/27	08 : 00	GlobeNewswire Inc.	PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds	NASDAQ:PRFX	PainReform Ltd
2023/11/16	06 : 09	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2023/11/16	06 : 05	GlobeNewswire Inc.	PainReform Provides Business Update for the Third Quarter of 2023	NASDAQ:PRFX	PainReform Ltd
2023/09/11	21 : 41	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PRFX	PainReform Ltd
2023/09/11	21 : 30	GlobeNewswire Inc.	PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery Following Positive FDA Review of Drug Master File	NASDAQ:PRFX	PainReform Ltd
2023/09/07	23 : 00	GlobeNewswire Inc.	PainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, Hungary	NASDAQ:PRFX	PainReform Ltd
2023/09/06	05 : 16	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PRFX	PainReform Ltd
2023/09/05	21 : 30	GlobeNewswire Inc.	PainReform to Participate in the H.C. Wainwright 25th Annual Global Investment Conference in New York City	NASDAQ:PRFX	PainReform Ltd
2023/09/05	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PRFX	PainReform Ltd